Abstract
Vitamin D is best known for its influence on skeletal health. There is growing recognition, however, that vitamin D has nonskeletal actions, which could have important implications for understanding the consequences of vitamin D deficiency. In epidemiologic studies, vitamin D deficiency has been consistently associated with an increased risk for cardiovascular disease and hypertension. Disruption of vitamin D signaling in animal models promotes hypertension, cardiac hypertrophy, and atherosclerosis. This evidence has led to the initiation of prospective randomized trials of vitamin D supplementation in individuals at risk for cardiovascular disease. The results of these trials should help to guide strategies for screening and management of vitamin D deficiency in the clinic and at the population level.
Original language | English (US) |
---|---|
Pages (from-to) | 261-272 |
Number of pages | 12 |
Journal | Annual review of medicine |
Volume | 67 |
DOIs | |
State | Published - Jan 14 2016 |
Externally published | Yes |
Keywords
- Cardiovascular disease
- Prevention
- Vitamin D
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)